MedPath

The Impact of Comprehensive Education Before Gastroscopy on Improving the Tolerance of Patients

Not Applicable
Completed
Conditions
Comprehensive Education
Registration Number
NCT03638752
Lead Sponsor
Ningbo No. 1 Hospital
Brief Summary

This clinical trial is being conducted to assess whether the comprehensive education before gastroscopy could reduce the adverse reactions, such as nausea, vomiting and improve patient satisfaction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
260
Inclusion Criteria
  1. Patients over the age of 18 years undergoing routine gastroscopy
  2. Informed consent
Exclusion Criteria
  1. Serious coronary heart disease and myocardial injury with serious heart failure
  2. Stenosis of the esophagus or cardia obstruction
  3. Acute pharyngitis and tonsillitis
  4. Acute upper gastrointestinal bleeding
  5. Hemodynamically unstable
  6. allergy to topical lidocaine
  7. Patients did not cooperate or spirit was not normal
  8. Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Adverse reaction times in gastroscopy1 day

research assistant records nausea/vomiting/retching times in the whole process of gastroscopy

Secondary Outcome Measures
NameTimeMethod
Patients' tolerance scores1 day

At the end of the procedure, the patients were asked about the tolerance in the process of gastroscopy by using a 100-mm visual analogue scale. Tolerance includes the extent of pain and nausea. The endpoints were assigned "no nausea or no pain " to the left and "worst possible nausea or worst pain imaginable " to the right.

Trial Locations

Locations (1)

Ningbo NO.1 hospital

🇨🇳

Ningbo, Zhejiang, China

Ningbo NO.1 hospital
🇨🇳Ningbo, Zhejiang, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.